Target Name: OR2M5
NCBI ID: G127059
Review Report on OR2M5 Target / Biomarker Content of Review Report on OR2M5 Target / Biomarker
OR2M5
Other Name(s): OR2M5P | OR2M5_HUMAN | olfactory receptor family 2 subfamily M member 5 | Olfactory receptor family 2 subfamily M member 5 | olfactory receptor, family 2, subfamily M, member 5 pseudogene | Olfactory receptor 2M5 | olfactory receptor 2M5

OR2M5: A Protein Implicated in Insulin Secretion and Glucose Uptake

OR2M5 (OR2M5P) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. Its function is not well understood, but it is known to be involved in the regulation of insulin secretion and glucose uptake. OR2M5 has been identified as a potential drug target and is the focus of ongoing research at the laboratory of Dr. Xinran Li at the University of California, San Diego.

The study of OR2M5 and its potential as a drug target began with a focus on its function in the regulation of insulin secretion. Insulin is a hormone that plays a critical role in maintaining blood sugar levels and is produced by the pancreas. When blood sugar levels are high, the pancreas releases insulin to help regulate them. However, when blood sugar levels are low, the pancreas does not release insulin. OR2M5 is known to be involved in the regulation of this process and has been shown to play a role in insulin secretion.

One of the ways that OR2M5 is involved in insulin secretion is through its regulation of the release of insulin from the pancreas. Studies have shown that OR2M5 can interact with the protein known as TrkB, which is a key regulator of insulin release. By modulating the activity of TrkB, OR2M5 has been shown to influence the amount of insulin released by the pancreas.

Another way that OR2M5 is thought to influence insulin secretion is through its effects on the cell surface of pancreatic beta cells. Beta cells are the cells that produce insulin, and they are the target of many drugs that are used to treat diabetes. OR2M5 has been shown to interact with the protein known as PDXL1, which is expressed on the surface of beta cells. This interaction may influence the ability of beta cells to respond to insulin and the production of insulin.

In addition to its role in insulin secretion, OR2M5 is also involved in the regulation of glucose uptake. Glucose is the body's primary source of energy, and it is important for maintaining brain function and maintaining a healthy blood sugar level. OR2M5 is known to be involved in the regulation of glucose uptake and utilization, which is the process by which glucose is taken up by cells and used as energy.

One of the ways that OR2M5 is involved in glucose uptake is through its regulation of the activity of the protein known as GLUT1. GLUT1 is a transmembrane protein that is involved in glucose uptake and utilization. OR2M5 has been shown to interact with GLUT1 and may influence its activity.

In conclusion, OR2M5 is a protein that is involved in the regulation of insulin secretion and glucose uptake. Its function is not well understood, but it is clear that it plays an important role in the regulation of these processes. As a potential drug target, OR2M5 is a focus of ongoing research at the laboratory of Dr. Xinran Li at the University of California, San Diego. Further studies are needed to fully understand the role of OR2M5 in insulin secretion and glucose uptake, and to determine the best way to use it as a therapeutic approach.

Protein Name: Olfactory Receptor Family 2 Subfamily M Member 5

Functions: Odorant receptor

The "OR2M5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR2M5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR2M7 | OR2Q1P | OR2S2 | OR2T1 | OR2T10 | OR2T11 | OR2T12 | OR2T2 | OR2T27 | OR2T29 | OR2T3 | OR2T33 | OR2T34 | OR2T35 | OR2T4 | OR2T5 | OR2T6 | OR2T7 | OR2T8 | OR2U1P | OR2V1 | OR2V2 | OR2W1 | OR2W1-AS1 | OR2W3 | OR2W5P | OR2W6P | OR2Y1 | OR2Z1 | OR3A1 | OR3A2 | OR3A3 | OR3A4P | OR4A14P | OR4A15 | OR4A16 | OR4A17P | OR4A21P | OR4A47 | OR4A5 | OR4B1 | OR4C11 | OR4C12 | OR4C13 | OR4C15 | OR4C16 | OR4C1P | OR4C3 | OR4C45 | OR4C46 | OR4C5 | OR4C50P | OR4C6 | OR4D1 | OR4D10 | OR4D11 | OR4D2 | OR4D5 | OR4D6 | OR4D9 | OR4E2 | OR4F13P | OR4F15 | OR4F16 | OR4F17 | OR4F21 | OR4F29 | OR4F3 | OR4F4 | OR4F5 | OR4F6 | OR4G3P | OR4K1 | OR4K13 | OR4K14 | OR4K15 | OR4K17 | OR4K2 | OR4K5 | OR4K6P | OR4K7P | OR4L1 | OR4M1 | OR4M2 | OR4M2-OT1 | OR4N2 | OR4N3P | OR4N4 | OR4N5 | OR4P4 | OR4Q3 | OR4S1 | OR4S2 | OR4T1P | OR4V1P | OR4X1 | OR4X2 | OR51A1P | OR51A2 | OR51A3P